Chlamydia trachomatis, a bacterial pathogen with a unique intracellular replication cycle, may cause a variety of clinical manifestations. These are linked to various serovars of the pathogen; trachoma to serovars A-C, oculogenital infections to serovars D-K, and lymphogranuloma venereum to serovars L1-L3. Nineteen serovars are known as human pathogens. The aim of the study was to determine the serovars of 401 C. trachomatis DNA positive extracts from original clinical specimens of patients in Austria including cervical and urethral swabs, urine, genital secretions and conjunctival swabs -collected from 2014 to 2017. Sequence analysis of the omp1 gene, encoding major outer-membrane protein was performed on each sample. In 50.1% of samples serovar E was identified and serovars F, D/Da and G/Ga were found in 16.2%, 9.7% and 9.0%, respectively. Remaining serovars were J (6.0%), K (4.7%), H (2.7%), B/Ba (1.0%), and I/Ia (0.5%). In 19 patients follow up samples could be tested. The majority of C. trachomatis serovars were associated with urogenital tract infections (D-K), however, one of them -serovar B/Ba -is linked to both, ocular and genital tract infection.
Results
Sequence analysis of the omp1 gene fragments showed that among the 401 C. trachomatis samples, serovar E was the type most frequently identified (201/401, 50.1%), followed by serovars F (65/401, 16.2%), D/Da (39/401, 9.7%), G/Ga (36/401, 9.0%), J (24/401, 6.0%), K (19/401, 4.7%), H (11/401, 2.7%), B/Ba (4/401, 1.0%) and I/ Ia (2/401, 0.5%). Information on the serovars and corresponding clinical samples are given in the Table 1 . We identified nine different serovars in samples from female patients and five from male patients. The majority of samples were obtained from the urogenital tract and included samples of urine. Ten samples were derived from ocular swabs, including one from a new born infant. C. trachomatis was repeatedly detected in 19 patients, the time intervals between the first and the follow-up examinations ranging from 19 to 919 days. Sixteen patients had one follow-up visit, two patients had three and one patient had four. In 17 patients the same C. trachomatis serovar was identified in the first and follow-up sample: serovar E was detected the most frequently (8 patients), followed by serovar D/Da (3 patients) and J (2 patients); serovars B/Ba, F, G/Ga and I/Ia were found repeatedly in one patient each. In two patients different serovars were found in the follow-up samples; in one patient serovar E followed serovar K, and in the other serovar H followed serovar E. With regard to patient age, the frequency of C. trachomatis infection was highest in patients aged 21-25 years (143 samples), followed by those aged 15-20 (95 samples) and 26-30 (84 samples) ( Fig. 1) . Serovar E was the most common in all the age groups, followed by serovars F and G/Ga. There were only two positive samples from patients aged below 15 years: one ocular infection in a newborn (serovar E), one genital infection in a teenager (serovar B/Ba).
Discussion
In 401 clinical specimens from Austrian patients who tested positive for C. trachomatis, omp1 PCR identified serovar E as the most common type (50.1%), followed by serovars F, D/Da, G/Ga, J, K, H, B/Ba and I/Ia. The serovars D-F are recognised as the most prevalent worldwide 2,3,7,8 . Serovar B/Ba, detected in a genital sample, was the only serovar from the ocular group of C. trachomatis; this serovar has already been described as causing ocular and genital tract disease 9 . The majority of samples tested were derived from female patients (95%), where the most frequent serovars were E and F; these were also prominent in the small number of samples from male patients. Serovar E was also detected in an ocular swab of a newborn.
We did not find serovars L1-L3 in our mainly female study population. Our aim was to get a first impression about C. trachomatis serovars obtained from clinical samples of Austrian patients. We identified eight different serovars of the oculogenital group, together with serovar B/Ba, one of the trachoma group and known as an agent of genital tract infection. We considered sequencing of the omp1 gene fragment by using Sanger sequencing an efficient method for this purpose. Multilocus sequence typing and next generation sequencing of C. trachomatis would be the next step to analyse the strains in more detail in order to compare their relation to other isolates and in respect to clinical manifestations. 
